Skip to content

Discontinued — last reported Q3 '22

Return on equity at other companies

Encompass Health Corporation logo
Encompass Health CorporationEHC
26%+0.7pp
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
15.3%-0.1pp
Addus HomeCare logo
Addus HomeCareADUS
9.4%+0.3pp
Astrana Health logo
Astrana HealthASTH
3.9%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
16.9%
National Healthcare logo
National HealthcareNHC
12.1%+0.9pp

Other financials

Income statement

See full
Revenue$647.9M+15.9%
Gross profit$205.4M+11.9%
Operating income$69.3M+33.8%
Net income$41.7M+702%
EPS (diluted)$0.19+533%

Balance sheet

See full
Cash & equivalents$189.3M+165%
Total debt$1.3B+1.0%
Total equity$240.1M+340%
Total assets$2.0B+21.8%

Cash flow

See full
Operating cash flow$4.3M+150%
CapEx$2.8M-33.4%
Free cash flow-$21.9M

Valuation

See full
Market cap$1.79B+60.6%
Enterprise value$2.93B+20.2%
P/E6.8×
P/S0.7×+0.2×

Profitability

See full
Gross margin33%+0.8pp
Operating margin10.9%+2.8pp
Net margin10.4%
FCF margin-2.5%

Returns & leverage

See full
Debt / equity5.6×
Current ratio1.5×+0.4×

Where this comes from

Calculated from Aveanna Healthcare Holdings Inc.’s reported figures.

Based on trailing twelve months.

The official record: Aveanna Healthcare Holdings Inc.’s 10-Q, filed November 15, 2022, on SEC EDGAR. View the filing →

Ask your AI about Aveanna Healthcare Holdings Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aveanna Healthcare Holdings Inc.'s return on equity?
Aveanna Healthcare Holdings Inc. (AVAH) reported return on equity of -112.1% in Q3 2022.
How has Aveanna Healthcare Holdings Inc.'s return on equity changed year-over-year?
Aveanna Healthcare Holdings Inc.'s return on equity decreased by 98634.9% year-over-year, from -0.1% to -112.1%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.